Abstract

Microparticles containing water-soluble zidovudine were prepared by spray-drying using chitosan glutamate and beta-glycerophosphate as an ion crosslinker (CF). The Box–Behnken design was applied to optimize the microparticles in terms of their drug loading and release behavior. Physicochemical studies were undertaken to support the results from dissolution tests and to evaluate the impact of the crosslinking ratio on the microparticles’ characteristics. The zidovudine dissolution behavior had a complex nature which comprised two phases: an initial burst effect followed with a prolonged release stage. The initial drug release, which can be modulated by the crosslinking degree, was primarily governed by the dissolution of the drug crystals located on the microparticles’ surfaces. In turn, the further dissolution stage was related to the drug diffusion from the swollen polymer matrix and was found to correlate with the drug loading. Differential Scanning Calorimetry (DSC) studies revealed the partial incorporation of a non-crystallized drug within the polymer matrix, which correlated with the amount of CF. Although CF influenced the swelling capacity of chitosan glutamate microparticles, surprisingly a higher amount of CF did not impact the time required for 80% of the drug to be released markedly. The formulation with the lowest polymer:CF ratio, 3:1, was selected as optimal, providing satisfactory drug loading and displaying a moderate burst effect within the first 30 min of the study, followed with a prolonged drug release of up to 210 min.

Highlights

  • Chitosan, a biocompatible polycationic copolymer, is obtained from abundantly accessible chitin in a deacetylation process [1]

  • This study aims at investigating the influence of microparticle composition, in particular the amount of introduced beta-glycerophosphate as an ion crosslinker (CF) on the release profile of water-soluble drugs from the chitosan matrix

  • The effect of microparticles composition on their characteristics and the release profile of water-soluble ZVD was investigated using design of experiments (DoE), a statistical tool related to the quality by design approach extensively applied in pharmaceutical technology at the stage of product development, process optimization, or validation

Read more

Summary

Introduction

A biocompatible polycationic copolymer, is obtained from abundantly accessible chitin in a deacetylation process [1]. It consists of randomly ordered N-acetylglucosamine and glucosamine units linked by β (1 → 4) glycosidic bonds. Due to its cationic nature, chitosan binds readily to mucosal surfaces and has been applied to a number of medical and pharmaceutical preparations, including drug carriers [2,3], wound dressings [4], scaffolds for tissue engineering [5] and nano-carriers [6]. We observed that chitosan in contact with vaginal fluid creates a swellable hydrogel matrix which may act as a barrier and support mucosal tissue against microbial infection [11]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call